LifeStance Health (LFST) Non-Current Deferred Tax Liability (2021 - 2025)
LifeStance Health (LFST) has disclosed Non-Current Deferred Tax Liability for 5 consecutive years, with $16.4 million as the latest value for Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 14.51% to $16.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.4 million, a 14.51% increase, with the full-year FY2025 number at $16.4 million, up 14.51% from a year prior.
- Non-Current Deferred Tax Liability was $16.4 million for Q4 2025 at LifeStance Health, up from $14.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $81.2 million in Q3 2021 to a low of $14.0 million in Q3 2025.
- A 5-year average of $35.2 million and a median of $37.6 million in 2023 define the central range for Non-Current Deferred Tax Liability.
- Peak YoY movement for Non-Current Deferred Tax Liability: crashed 60.37% in 2024, then rose 14.51% in 2025.
- LifeStance Health's Non-Current Deferred Tax Liability stood at $54.3 million in 2021, then decreased by 28.7% to $38.7 million in 2022, then crashed by 59.76% to $15.6 million in 2023, then decreased by 7.98% to $14.3 million in 2024, then grew by 14.51% to $16.4 million in 2025.
- Per Business Quant, the three most recent readings for LFST's Non-Current Deferred Tax Liability are $16.4 million (Q4 2025), $14.0 million (Q3 2025), and $14.1 million (Q2 2025).